Skip to main content
Top
Published in: Indian Journal of Gastroenterology 1/2014

01-01-2014 | Original Article

Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India

Authors: Ajit Sood, Vandana Midha, Omesh Goyal, Prerna Goyal, Neena Sood, Suresh Kumar Sharma

Published in: Indian Journal of Gastroenterology | Issue 1/2014

Login to get access

Abstract

Purpose/Aim

Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality in all parts of the world. We analyzed the clinical presentation, etiology, and tumor characteristics of HCC presenting to our hospital.

Methods

All patients diagnosed to have HCC from September 2007 to August 2010 were prospectively enrolled. HCC was diagnosed according to EASL criteria—USG/CT/MRI of the abdomen and/or serum alpha-fetoprotein and/or histology (where indicated). Detailed clinical and laboratory parameters were noted. Barcelona Clinic Liver Cancer (BCLC) staging was done.

Results

One hundred and twenty-eight patients (22 females, mean±SD; age, 49.8 ± 10.2 years) were diagnosed to have HCC. Underlying cirrhosis was present in 99.2 %. Hepatitis C virus infection, alone (21.9 %) or with alcohol (22.9 %) was the most common etiological factor, followed by alcohol alone; 33.6 % of the patients had more than one etiological factor. Most patients (83.5 %) presented with features of decompensated cirrhosis. HCC leading to decompensation of cirrhosis was the first presentation of the liver disease in nearly one third of the cases. Serum alpha-fetoprotein was >200 ng/mL in 67.2 % of the patients, while it was normal in 18.7 % of the patients. The mean±SD size of HCC was 5.3 ± 2.9 cm. HCC was multicentric in 57 %, and portal vein thrombosis was present in 34.4 %. About 66 % of the patients belonged to BCLC stage C or D.

Conclusions

Hepatitis C virus infection was the most common cause of HCC in Punjab. One-third of the patients had multiple etiological factors and almost all had underlying cirrhosis and presented at advanced stage.
Literature
1.
go back to reference Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.PubMedCrossRef Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.PubMedCrossRef
2.
go back to reference Parkin D, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.PubMedCrossRef Parkin D, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.PubMedCrossRef
4.
go back to reference Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987;47:4967–72.PubMed Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987;47:4967–72.PubMed
5.
go back to reference Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979–94. Lancet. 1997;350:1142–3.PubMedCrossRef Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979–94. Lancet. 1997;350:1142–3.PubMedCrossRef
6.
go back to reference Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet. 1998;351:214–5.PubMedCrossRef Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet. 1998;351:214–5.PubMedCrossRef
7.
go back to reference Stroffolini T, Andreone P, Andriulli A, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol. 1998;29:944–52.PubMedCrossRef Stroffolini T, Andreone P, Andriulli A, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol. 1998;29:944–52.PubMedCrossRef
8.
go back to reference El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50.PubMedCrossRef El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50.PubMedCrossRef
9.
go back to reference Annual Report 1987. National Cancer Registry Programme. New Delhi, Indian Council of Medical Research, 1990 Annual Report 1987. National Cancer Registry Programme. New Delhi, Indian Council of Medical Research, 1990
10.
go back to reference Jayant K, Rao RS, Nene BM, Dale PS. Rural cancer registry at Barshi—Report 1988–92. Rural Cancer Registry: Barshi; 1994. Jayant K, Rao RS, Nene BM, Dale PS. Rural cancer registry at Barshi—Report 1988–92. Rural Cancer Registry: Barshi; 1994.
11.
go back to reference Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. Q J Med. 2008;101:479–85.CrossRef Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. Q J Med. 2008;101:479–85.CrossRef
13.
go back to reference Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77:162–71.PubMedCrossRef Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77:162–71.PubMedCrossRef
14.
go back to reference Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case–control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007;22:1104–11.PubMedCrossRef Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case–control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007;22:1104–11.PubMedCrossRef
15.
go back to reference Saini N, Bhagat A, Sharma S, Duseja A, Chawla Y. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center. Clin Chim Acta. 2006;371:183–6.PubMedCrossRef Saini N, Bhagat A, Sharma S, Duseja A, Chawla Y. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center. Clin Chim Acta. 2006;371:183–6.PubMedCrossRef
16.
go back to reference Joshi N, Kumar A, Rani MS, Chandra N, Ramanjaneyulu ER. Clinical and aetiological profile of hepatoma at a tertiary care centre. Trop Gastroenterol. 2003;24:73–5.PubMed Joshi N, Kumar A, Rani MS, Chandra N, Ramanjaneyulu ER. Clinical and aetiological profile of hepatoma at a tertiary care centre. Trop Gastroenterol. 2003;24:73–5.PubMed
17.
go back to reference Sharma S, Sharma B, Chawla YK, et al. Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma. Trop Gastroenterol. 2010;31:271–8.PubMed Sharma S, Sharma B, Chawla YK, et al. Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma. Trop Gastroenterol. 2010;31:271–8.PubMed
18.
19.
go back to reference Durga R, Muralikrishna P. Viral markers in hepatocellular carcinoma. Indian J Gastroenterol. 1994;13:A57. Durga R, Muralikrishna P. Viral markers in hepatocellular carcinoma. Indian J Gastroenterol. 1994;13:A57.
20.
go back to reference Kar P, Budhiraja S, Narang A, Das BC, Panda SK, Chakravorty A. Comparative evaluation of serology and polymerase chain reaction for hepatitis C viral infection in liver diseases. Indian J Gastroenterol. 1997;16:118–9.PubMed Kar P, Budhiraja S, Narang A, Das BC, Panda SK, Chakravorty A. Comparative evaluation of serology and polymerase chain reaction for hepatitis C viral infection in liver diseases. Indian J Gastroenterol. 1997;16:118–9.PubMed
21.
go back to reference Sarin SK, Thakur V, Guptan RK, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666–73.PubMedCrossRef Sarin SK, Thakur V, Guptan RK, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666–73.PubMedCrossRef
22.
go back to reference Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, (eds). Liver Cancer. New York: Churchill Livingstone; 1997. p. 13–27. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, (eds). Liver Cancer. New York: Churchill Livingstone; 1997. p. 13–27.
23.
go back to reference Pyrsopoulos N, Reddy RK. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, (eds). Hepatitis B and C. Carrier to Cancer. Elsevier Sciences: India; 2002. p. 363–4. Pyrsopoulos N, Reddy RK. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, (eds). Hepatitis B and C. Carrier to Cancer. Elsevier Sciences: India; 2002. p. 363–4.
24.
go back to reference Park YM. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, (eds). Hepatitis B and C. Carrier to Cancer. India: Elsevier; 2002. p. 268–71. Park YM. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, (eds). Hepatitis B and C. Carrier to Cancer. India: Elsevier; 2002. p. 268–71.
25.
go back to reference Aggarwal R, Naik SR. Prevention of hepatitis B infection: the appropriate strategy for India. Natl Med J India. 1994;7:216–20.PubMed Aggarwal R, Naik SR. Prevention of hepatitis B infection: the appropriate strategy for India. Natl Med J India. 1994;7:216–20.PubMed
26.
go back to reference Bosch FX, Ribes J, Diaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127 5, Suppl 1:S5–S16. Bosch FX, Ribes J, Diaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127 5, Suppl 1:S5–S16.
27.
go back to reference Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.PubMedCrossRef Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.PubMedCrossRef
28.
go back to reference Sundaram C, Reddy CR, Venkataramana G, et al. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India—an autopsy study. Indian J Pathol Microbiol. 1990;33:334–8.PubMed Sundaram C, Reddy CR, Venkataramana G, et al. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India—an autopsy study. Indian J Pathol Microbiol. 1990;33:334–8.PubMed
29.
go back to reference Kumar A, Sreenivas DV, Nagarjuna YR. Hepatocellular carcinoma. The Indian scenario. Indian J Gastroenterol. 1995;14:A95. Kumar A, Sreenivas DV, Nagarjuna YR. Hepatocellular carcinoma. The Indian scenario. Indian J Gastroenterol. 1995;14:A95.
30.
go back to reference Abbasi A, Butt N, Bhutto AR, Gulzar K, Munir SM. Hepatocellular carcinoma: a clinicopathological study. J Coll Physicians Surg Pak. 2010;20:510–3.PubMed Abbasi A, Butt N, Bhutto AR, Gulzar K, Munir SM. Hepatocellular carcinoma: a clinicopathological study. J Coll Physicians Surg Pak. 2010;20:510–3.PubMed
31.
go back to reference Butt AK, Khan AA, Alam A, et al. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc. 1998;48:197–201.PubMed Butt AK, Khan AA, Alam A, et al. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc. 1998;48:197–201.PubMed
32.
go back to reference Ramesh R, Munshi A, Panda SK. Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol. 1992;7:393–5.PubMedCrossRef Ramesh R, Munshi A, Panda SK. Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol. 1992;7:393–5.PubMedCrossRef
33.
go back to reference Patil S, Bhuyan BK, Nanda BK. A study of ninety-three cases of primary carcinoma of liver. Indian J Pathol Microbiol. 1982;25:135–8.PubMed Patil S, Bhuyan BK, Nanda BK. A study of ninety-three cases of primary carcinoma of liver. Indian J Pathol Microbiol. 1982;25:135–8.PubMed
34.
go back to reference Prabhakar V, Rao KS, Reddy DJ. Primary carcinoma of liver in Vishakhapatnam. Indian J Pathol Microbiol. 1966;9:54–60. Prabhakar V, Rao KS, Reddy DJ. Primary carcinoma of liver in Vishakhapatnam. Indian J Pathol Microbiol. 1966;9:54–60.
Metadata
Title
Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India
Authors
Ajit Sood
Vandana Midha
Omesh Goyal
Prerna Goyal
Neena Sood
Suresh Kumar Sharma
Publication date
01-01-2014
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2014
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-013-0373-7

Other articles of this Issue 1/2014

Indian Journal of Gastroenterology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.